Table 3.

Effect of analyzed compounds on fibrinolysis parameters—thromboelastometric data

Compounds	LOT (s)	LT (min)	LI30–LI45–LI60 (%)
Control	1993 ± 111	48 ± 4	91–39–2
H–EACA–OH	≥4084	≥168	100–98–92
H–EACA–NH2	2488 ± 172	71 ± 5	96–80–32
H–Ala–Phe–Lys–EACA–NH2	2731 ± 160	76 ± 6	99–86–43
H–D-Ala–Phe–Lys–EACA–NH2	2519 ± 176	72 ± 4	97–79–28

LOT lysis onset time—time from the start of coagulation to the point which the amplitude of formed clot is reduced by 15 % (s). LT lysis time, when clot is reduced/lysed by 90 % (s). LI30–LI45–LI60 Lysis index amplitude of clot (%) after 30, 45, 60 min (%). Control without synthesized peptides